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Abstract  This  study  aimed  to  analyze  the  effects  of  psychological  treatments  on  quality  of
life among  cancer  patients  and  survivors.  Additionally,  it  was  explored  the  moderating  inﬂuence
of some  medical-  and  treatment-related  features  on  these  effects.  Scientiﬁc  studies  published
between  1970  and  2012  were  analyzed.  Seventy-eight  studies  were  included  in  a  meta-analysis.
Concerns  related  to  samples,  interventions,  and  standard  of  methodological  evidence  were
explored across  the  studies.  A  signiﬁcant  overall  effect  size  of  psychological  interventions  was
revealed (g  =  .35).  Clinical  state  and  use  of  adjuvant  psychological  treatment  for  managing
medical side  effects  moderated  this  result  (p  <  .05).  Furthermore,  a  meta-regression  model  was
showed signiﬁcant  (R2 =  .30)  so  as  to  explain  the  quality  of  life  change  associated  with  psy-
chological interventions.  The  psychotherapeutic  beneﬁts  on  depressive  symptomatology  were
included as  a  moderating  factor.  To  sum  up,  quality  of  life  is  improved  by  psychological  inter-
ventions, especially  when  patients  have  to  cope  with  medical  treatment  or  with  adjustment
after the  disease  is  treated.  Psychological  treatments  tend  to  promote  better  outcomes  when
depressive  symptomatology  is  managed.  These  ﬁndings  support  that  providing  psychological
treatments  should  be  considered  as  crucial  for  the  patient’s  health  in  cancer  contexts.
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Tratamientos  psicológicos  para  mejorar  la  calidad  de  vida  en  contextos  oncológicos:
un  meta-análisis
Resumen  Este  estudio  pretende  conocer  el  efecto  de  los  tratamientos  psicológicos  sobre  la
calidad de  vida  de  pacientes  y  supervivientes  de  cáncer,  así  como  la  inﬂuencia  moderadora
de variables  médicas  y  propias  del  tratamiento  sobre  dicho  efecto.  Para  ello,  se  realizó  un
meta-análisis  que  incluyó  78  trabajos  publicados  entre  1970  y  2012.  Se  analizaron  aspectos
relacionados  con  la  muestra,  el  tratamiento  y  la  calidad  metodológica  de  estos  estudios.  Como
resultado,  se  encontró  un  taman˜o  del  efecto  signiﬁcativo  de  los  tratamientos  psicológicos
sobre la  calidad  de  vida  (g  =  0,35).  Dicho  efecto  estaba  moderado  por  el  estado  clínico  del
paciente  y  la  adyuvancia  del  tratamiento  psicológico  con  el  médico  (p  <  0,05).  También  se
observó que  mayores  reducciones  de  sintomatología  depresiva  debidas  al  tratamiento  llev-
aban a  mayores  beneﬁcios  sobre  la  calidad  de  vida  según  las  meta-regresiones  ejecutadas
(R2 =  0,30).  En  conclusión,  los  tratamientos  psicológicos  pueden  mejorar  la  calidad  de  vida  de
pacientes  oncológicos,  principalmente  cuando  deben  afrontar  tratamientos  médicos,  así  como
de los  supervivientes.  Además,  cuando  se  reduce  la  sintomatología  depresiva  la  calidad  de  vida
suele mejorar.  Estos  resultados  destacan  la  inﬂuencia  decisiva  de  los  tratamientos  psicológicos
para la  salud  integral  en  contextos  oncológicos.
© 2015  Asociación  Espan˜ola  de  Psicología  Conductual.  Publicado  por  Elsevier  España,  S.L.U.
Este es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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for  Protocols  2015  (PRISMA-P  2015)  statement  (Moher  et  al.,Quality  of  life  (QoL)  refers  to  a  whole,  integrated  state  of
hysical,  mental  and  socioemotional  well-being.  This  multi-
imensional  construct  is  eminently  subjective  and  may  be
easured  through  varying  indicators,  such  as  health  sta-
us  or  personal  functioning  (Ferguson  &  Cull,  1991;  World
ealth  Organization,  WHO,  1948).  QoL  entails  more  than  a
ere  absence  of  disease,  although  it  is  profoundly  associ-
ted  with  its  severity  (Amedro  et  al.,  2014;  Hogg,  Peach,
rice,  Thompson,  &  Hinchliffe,  2012;  Pagels,  Söderkvist,
edin,  Hylander,  &  Heiwe,  2012).  For  cancer  patients,  QoL
s  a  crucial  concern  both  when  cancer  is  present  and  when
he  disease  has  been  treated  (Cheng  et  al.,  2012;  Costa-
equena,  Rodríguez,  &  Fernández-Ortega,  2013).  Oncologic
edical  treatments  lead  to  QoL  improvements,  but  some-
imes  a  wide  variety  of  side  effects  can  arise  and  bring  about
igniﬁcant  health-related  complaints  (Decat,  de  Araujo,  &
tiles,  2011;  Gogou  et  al.,  2015;  Goh,  Steele,  Jones,  &
unro,  2013).  Likewise,  when  cancer  is  treated,  patients
how  higher  levels  of  QoL,  but  physical  and  psycholog-
cal  sequelae  often  diminish  it  (Bardwell  &  Fiorentino,
012;  Duijts  et  al.,  2014;  Howard-Anderson,  Ganz,  Bower,
 Stanton,  2012).
Facing  a  cancer  or  its  sequelae  may  lead  to  signiﬁcant
sychological  distress  and  psychiatric  symptomatology,  such
s  sleep  difﬁculty,  excessive  worries  regarding  survival  and
epressive  mood.  These  symptoms  are  often  associated  with
ower  QoL  and  well-being  (Bornbaum  et  al.,  2012;  Oh,  Seo,
eong,  &  Seo,  2012).  A  wide  range  of  psychological  interven-
ions  may  be  applied  to  ameliorate  the  psychological  distress
nd  the  adjustment  to  being  a  cancer  patient,  subsequently
nhancing  QoL  (Badr  &  Krebs,  2013;  Preyde  &  Synnott,
009).  Rehse  and  Pukrop  (2003)  conducted  a  meta-analytic
eview  in  order  to  study  the  overall  effect  of  psychological
reatments  throughout  the  cancer  recovery  process.  They
ound  a  medium  overall  effect  size  (d  =  .65),  though  treat-
ent  length  showed  a  signiﬁcant  moderating  effect.
2
E
PMore  recently,  another  meta-analysis  was  conducted  with
imilar  purposes.  Faller  et  al.  (2013)  studied  the  effect  of
sychological  treatments  on  emotional  distress  and  QoL.  In
his  case,  psychological  treatments  were  observed  to  yield
 small  overall  effect  size  for  QoL  (d  =  .26).  Moreover,  type
f  treatment  was  found  to  be  a  signiﬁcant  modulating  fac-
or  regarding  this  effect,  pointing  to  healthier  outcomes
hen  relaxation  programs  were  applied,  for  instance.  These
esults  differed  from  those  found  in  the  prior  meta-analysis,
robably  due  to  the  differences  in  sample  selection  criteria
or  both  studies;  as  well  as  the  different  conceptualizations
f  QoL  and  psychological  treatment.
Because  of  these  discrepancies,  this  study  aimed  to  ana-
yze  the  overall  effect  size  of  psychological  treatments  on
oL  in  cancer  patients  and  survivors.  It  thereby  considered
ollowing  the  methodology  proposed  by  Rehse  and  Pukrop
2003)  for  this  purpose;  however,  QoL  was  studied  from
 multidimensional  point  of  view.  Furthermore,  this  study
imed  to  test  whether  effect  sizes  should  be  considered
egarding  disease-based  features,  treatment-related  con-
iderations,  or  methodology-related  variables.  Finally,  the
resence  of  signiﬁcant  models  to  explain  QoL  effects  of
hese  treatments  in  relation  to  medical-related  concerns,
nd  psychopathology  was  studied.
ethods
tudy  selection  criteria
his  meta-analysis  is  reported  according  to  the  Preferred
eporting  Items  for  Systematic  Reviews  and  Meta-Analyses015)  and  Botella  and  Gambara  (2006)  recommendations.
ligibility  criteria  for  studies  are  detailed  according  to  the
ICOS  framework  as  follows.
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Table  1  Search  strategy  adaptations  for  each  database.
Database  Search  strategy
CINAHL  Boolean:
((neoplasm)  or  (cancer))
AND  (psychotherapy)  AND
(‘‘quality  of  life’’)
Cochrane  Database  NEOPLASM  AND
PSYCHOTHERAPY  AND
‘‘QUALITY  OF  LIFE’’  [1999  -
2012]
Filter:  RCT
Ovid  SP  Nursing  Database ((neoplasm)  or  (cancer))
AND  (psychotherapy)  AND
(‘‘quality  of  life’’)
Proquest:
MEDLINE® (1999-2012)
ProQuest  Health  &
Medical  Complete
ProQuest  Library  Science
(1970-2012)
ProQuest  Psychology
Journals  PsycARTICLES
(1894-2012)
PsycCRITIQUES
(1995-2012)
PsycINFO  (1806-2012)
PsycTESTS
all((neoplasm)  or  (cancer))
AND  all(psychotherapy)  AND
all(‘‘quality  of  life’’)
PubMed  (‘‘Neoplasms’’[Mesh])  AND
(‘‘Psychotherapy’’[Mesh])
AND  (‘‘Quality  of
Life’’[Mesh])
Filter:  RCT
Psicodoc  ((neoplas*)  o  (cancer))  y
(psicoterapia)  y  (calidad  de
vida)
Scopus (TITLE-ABS-KEY(neoplasm
OR  cancer)  AND  TITLE-ABS-
KEY(psychotherap*)  AND
TITLE-ABS-KEY(‘‘quality  of
life’’))  AND  PUBYEAR  >  1998
AND  (LIMIT-TO(LANGUAGE,
‘‘English’’)  OR
LIMIT-TO(LANGUAGE,
‘‘Spanish’’))  AND
(LIMIT-TO(DOCTYPE,  ‘‘ar’’))
AND  (LIMIT-TO(SRCTYPE,
‘‘j’’))
Web of  Science Topic  =  ((neoplasm  or
cancer))  AND
Topic  =  (psychotherapy)  AND
Topic  =  (‘‘quality  of  life’’)
Timespan  =  1999-01-01  -
2012-12-20.
Databases  =  SCI-EXPANDED,
SSCI,  A&HCI.
Lemmatization  =  OnPsychological  treatments  to  improve  quality  of  life  in  cance
Participants. Studies  with  samples  composed  of  adults
who  suffer  from  malignant  tumors  or  cancer  survivors  were
selected.  Studies  that  included  patients  suffering  from  a
benign  tumor  were  ruled  out.
Interventions.  Studies  focusing  on  analyzing  the  effect  of
a  psychological  intervention  on  QoL  were  included.  Psycho-
logical  intervention  was  deﬁned  as  nonpharmacologic  inter-
vention  using  psychological  procedures:  psycho-education,
coping  skills  training,  counselling,  relaxation,  alone  or  in
combination,  and  psychotherapy  (see  Hodges  et  al.,  2011).
These  interventions  are  applied  in  order  to  improve  either
mental  or  health-related  outcomes.  Studies  with  non  psy-
chological  interventions,  such  as  physiotherapy,  physical
training  or  others  were  excluded.
Controls.  Studies  that  compared  the  effect  of  a  psycho-
logical  treatment  with  a  control  group  (either  a  placebo
group  or  a  wait-list  group)  were  selected.
Outcomes.  Primary  outcome  was  quality  of  life  (mea-
sured  by  self-reports),  conceptualized  from  a  multidimen-
sional  point  of  view  (WHO,  1948);  namely,  perceived  state
of  well-being  as  a  whole,  including  physical,  mental  and
socioemotional  aspects.  This  outcome  can  be  measured
through  direct  indicators  (health  status  and  well-being)  as
well  as  more  indirect  ones  (patient’s  functioning  tests).
Secondarily,  other  self-reported  outcomes  were  considered:
anxiety  (measured  mainly  by  using  BAI,  HADS,  STAI),  depres-
sion  (BDI,  CES-D,  HADS  as  most  used  instruments),  and
fatigue  (FSI,  MFI,  a  subscale  of  FACT-F,  as  most  commonly
used  instruments).
Studies.  Randomized  controlled  trials  published  between
1970  and  2012  in  scientiﬁc  press  (written  in  English  and
Spanish  languages)  were  selected.  Papers  that  did  not  give
enough  data  to  extract  the  required  effect  sizes  were  ruled
out.
Study  selection  procedure
Studies  were  selected  by  reviewing  the  meta-analysis  of
Rehse  and  Pukrop  (to  select  articles  between  1970-1999)
and  four  issue-related  ones  (Badr  &  Krebs,  2013;  Faller
et  al.,  2013;  Osborn,  Demoncada,  &  Feuerstein,  2006;
Preyde  &  Synnott,  2009).  Additionally,  it  was  conducted
some  database  searches  (March,  2013).  As  key  terms,
‘neoplasm(s)’,  ‘psychotherapy’,  and  ‘quality  of  life’  were
considered;  as  was  the  reference  study  (Rehse  &  Pukrop,
2003).  Search  queries  are  attached  in  Table  1.
Each  study  was  selected  when  two  reviewers  inde-
pendently  considered  it  satisﬁed  the  selection  criteria.
Thus,  papers  were  screened  through  an  initial  review  of
title,  abstract,  and  keywords.  Afterwards,  the  pre-selected
manuscripts  were  read  fully  to  endorse  the  selection  crite-
ria  were  satisﬁed.  Meanwhile,  a  descendent  search  process
was  performed:  all  the  articles  cited  in  selected  manuscripts
were  reviewed.
Outcome  domains  and  coded  variablesRelevant  data  of  the  studies  were  extracted  and  coded  using
a  database  developed  for  these  purposes  by  a  reviewer.
Furthermore,  the  other  one  tested  coding  tools  by  reading
and  categorizing  a  random  selection  of  the  study  sample.
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Table  2  Categorical  variables  considered  in  this  meta-
analysis.
Variables  Coding  categories
Type  of  cancer  Breast  cancer
Lung  cancer
Prostate  cancer
Others
Patient’s  clinical  state  Active  treatment
Terminal  illness
Remission  (survivors)
Samples  composed  of  patients
with  different  states
Adjuvant  psychological
treatment
No  adjuvancy
Psychological  interventions  to
palliate  side  effects  of  medical
treatments
Type of  psychological
intervention*
Psychoeducational
interventions
Support  groups
Coping  skills  training  programs
Psychotherapy
Format  of  intervention  Individual
Couple
Group  treatment
Mixed  formats
Duration  of  treatment  Short  interventions  (<  15
sessions)
Long  interventions  (≥  15
sessions)
Instrument  to  measure
QoL†
QoL  as  a  whole
Health-related  QoL
Cancer-speciﬁc  QoL
Treatment-speciﬁc  QoL
Methodological  quality  of
studies‡
Strong  quality
Moderate  quality
Low  quality
Note.
* Classiﬁed according to Cunningham (1995), although spir-
itual/existential therapies were considered a branch of
psychotherapies.
† According to Murphy, Ridner, Wells, and Dietrich (2007). The
fourth category was included because there are many instru-
ments adapted for each type of deﬁnite oncologic intervention
instead of symptom-speciﬁc QoL (in this meta-analysis QoL was
considered as a multidimensional construct).
‡ Assessed using the Quality Assessment Tool for Quantitative
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m14  
his  selection  encompassed  25%  of  the  total  sample.  As  a
esult,  80%  of  the  relevant  data  were  equally  coded  by  the
wo  reviewers,  2 (1)  =  63.00,  p  <  .01.  Disagreements  were
esolved  by  discussion.
As  a  dependent  variable,  the  effect  size,  extracted  by
omparing  QoL  scores  between  experimental  and  control
roup  after  psychological  treatment  was  applied,  was  cal-
ulated.  Data  were  collected  by  validated  instruments  that
ssessed  QoL  from  concepts  such  as  integrated  sense  of
ell-being,  as  well  as  integrated  perception  of  health  and
unctioning.  Most  used  instruments  are  stated  in  Ferguson
nd  Cull  (1991).
Eight  categorical  factors  were  considered  in  this  meta-
nalysis  (see  Table  2).  Additionally,  several  quantitative
oderating  factors  were  studied:  the  mean  age  of  par-
icipants,  gender-related  proportions  within  samples  and
linical  symptomatology  (levels  of  depression,  anxiety,  and
ancer-related  fatigue).
ata  analyses
 single  effect  size  was  calculated  for  each  study,  for  the
ependent  variable  as  well  as  for  the  quantitative  clinical
actors.  These  calculations  were  based  on  the  standardized
ifference  of  group  means  after  psychological  treatment
y  using  the  Hedges’  g  statistic  (Botella  &  Gambara,  2002;
edges  &  Olkin,  1985).  The  unbiased  estimator  of  g  based
n  gamma  function  was  therefore  applied  (see  Equation  1).
ffect  sizes  were  interpreted  according  to  the  guidelines  by
ohen  (1988).
 =  d•[c(m)]  (1)
Different  rules  were  used  in  order  to  avoid  dependency
etween  measures.  Firstly,  if  there  was  more  than  one
xperimental  group,  the  group  whose  psychological  treat-
ent  was  more  common  was  considered.  If  there  was  more
han  one  instrument  to  measure  QoL  in  a  study,  only  the
nstrument  showing  the  highest  reliability  was  chosen.  Addi-
ionally,  the  overall  effect  size  was  calculated.  This  was
eighted  by  the  inverse  of  variance  of  the  single  effect
izes  (see  Equation  2),  which  is  obtained  through  the  single
ntra-study  variability  and  an  estimate  of  the  between-study
ariance  (Botella  &  Gambara,  2002).
=
∑k
i=1wi ∗  gi∑k
i=1wi
(2)
Afterwards,  homogeneity  between  studies  was  tested  for
y  using  the  Qt statistic  and  the  I2 index  (Hedges  &  Olkin,
985;  Higgins  &  Thompson,  2002).  If  the  null  hypothesis  was
ejected  for  this  test,  the  presence  of  explanatory  models
ad  to  be  studied  in  order  to  ﬁnd  factors  related  to  these
ystematic  variations.
Explanatory  model  ﬁtting  was  therefore  considered.  We
rstly  analyzed  the  magnitude  of  moderating  effects  derived
rom  coded  categorical  factors  by  means  of  analogues  of
nalysis  of  variance  (Hedges  &  Pigott,  2004).  Forest  plots
ere  attached  to  complement  these  analyses  visually.
All  of  these  calculations  were  conducted  assuming  ran-
om  effects  models  (Hedges  &  Pigott,  2004;  Sánchez-Meca,
arín,  &  Huedo,  2006).
e
e
b
2Studies (Thomas, Ciliska, Dobbins, & Micucci, 2004).
Meanwhile,  quantitative  model  ﬁtting  was  also  tested
y  means  of  multiple  meta-regression.  The  factors  con-
idered  were  incorporated  into  two  different  models:  one
omprising  sociodemographic  and  medical  related  factors
gender,  sample  age,  clinical  state,  use  of  adjuvant  psy-
hological  interventions  for  managing  the  side  effects  of
edical  treatment,  and  fatigue);  another  that  involved
motional  symptomatology  (anxiety  and  depression).  Model
stimations  were  extracted  by  using  maximum  likelihood
ased  methods  (Botella  &  Gambara,  2002;  Hedges  &  Pigott,
004).
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Descending search approach
Search results combined
(n=1,330)
Ascending search approach ( n=17)
Excluded for not satisfying
Excluded for not satisfying
- Sample criteria ( n=92)
- Intervention criteria ( n=99)
- Controls criteria ( n=9)
- Outcomes criteria (n=225)
- Study criteria (n=639)
- Sample criteria ( n=4)
- Intervention criteria ( n=6)
- Controls criteria ( n=10)
- Outcomes criteria (n=92)
- Study criteria (n=76)
Screening review
Included ( n=266)
Included ( n=78)
Manuscript review
- Rehse and pukrop meta-analysis (n=37)
- Database (n=1,110) and meta-analyses ( n=166)
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sFigure  1  Flow  diagram  of  study  selection.
Note.  Screening  review  was  based  on  title  article,  abstract,  and
Finally,  publication  bias  was  assessed  by  using  contour-
enhanced  funnel  plots  and  the  Egger’s  regression  test  (see
Mavridis  &  Salanti,  2014).
SPSS  v.  19  (script  by  Lipsey  &  Wilson,  2001)  and  R x64
3.0.1  (METAFOR  1.9-1  package)  were  used  to  conduct  these
analyses.
Results
Figure  1  depicts  the  steps  followed  to  obtain  the  study  sam-
ple.  An  initial  sample  of  1330  original  papers  was  reviewed.
Upon  the  study  selection  stage  was  over,  78  studies  were
deﬁnitely  included  in  this  meta-analysis*.  Study  reviewers
agreed  on  sample  selection.  All  of  these  studies  were  writ-
ten  in  the  English  language.  The  bulk  of  studies  showed  a
medium  level  of  methodological  quality  (60.20%  of  sample)
in  contrast  with  strong  and  weak  levels  (24.40%  and  15.40%,
respectively).
A  total  of  7,342  individuals  composed  the  studies.  Mean
age  of  participants  was  54.82  years  old  (SD  =  7.36).  Regarding
the  type  of  oncologic  disease,  almost  half  of  the  studies
were  focused  on  samples  with  breast  cancer  (46.20%  of
studies).  Moreover,  the  studies  were  mainly  focused  on  sam-
ples  under  oncologic  medical  treatment  (82.90%  of  studies,
respectively).
Regarding  the  use  of  adjuvant  psychological  treatment,
14.10%  of  studies  tested  the  effects  of  psychological  treat-
ment  on  adverse  symptomatology  derived  from  a  medical
∗ List of studies and codiﬁcation manual are available upon
request from the corresponding author.
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reatment.  Regarding  the  type  of  psychological  treatment,
he  most  common  type  was  psychotherapy  (46.80%  of
tudies);  while  the  most  common  format  was  individual
reatment  (54.10%  of  studies)  and  short-term  ones  (76.30%
f  studies).
Considering  how  QoL  was  assessed,  more  than  the  half  of
he  studies  used  instruments  that  evaluate  health-related
oL;  fewer  studies  used  instruments  that  measure  generic
oL  cancer-speciﬁc  or  treatment-speciﬁc  QoL  (24.40%,
9.20%  and  3.80%  of  studies,  respectively).
Instruments  used  to  measure  QoL  showed  adequate  lev-
ls  of  reliability,  as  Cronbach’s  alpha  statistic  conﬁrmed
Mdn  =  .89,  range  = [.69,  .95]),  as  well  as  those  used  to
easure  depression  (Mdn  =  .82,  range  =  [.70,  .91]),  anxiety
Mdn  =  .85,  range  =  [.74,  .93]),  and  cancer-related  fatigue
Mdn  =  .93,  range  =  [.82,  .97]).
istribution  of  effect  sizes
ingle  effect  sizes  in  relation  to  the  effect  of  psychological
reatment  on  QoL  ranged  between  -.41  and  2.37  and  study
ariances  between  .01  and  .59.  Regarding  overall  effect
ize,  it  was  found  that  g  =  .35,  CI95 =  (.25,  .45),  with  contrast
tatistic  Zc =  7.51;  p  <  .01.  The  between-study  variability  was
 =  .10  among  the  78  studies  analyzed.  These  results  sug-
est  the  presence  of  a small-to-medium  overall  effect  size
f  psychological  treatments  on  QoL.
Afterwards,  the  homogeneity  tests  revealed  a signiﬁcant
eterogeneity  between  studies,  Qt (77)  =  243.80;  p  <  .01;  and
2 =  68.42%.  These  ﬁndings  suggest  that  differences  between
ingle  effect  sizes  were  too  large  to  consider  being  due  to
andom  effects.
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Patients under
medical treatment
Non-adjuvant
treatment
Adjuvant
psychological
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Overall ES
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Overall ES
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.35 [.25, .35]
.29 [.19, .39]
.74 [.49, .99]
.35 [.25, .45]
ES quality of lifeA B
.70 .00 .40 .80
ES quality of life
Figure  2  Overall  effect  sizes  in  relation  to  signiﬁcant  categorical  models.
Note. This  ﬁgure  includes  overall  effect  sizes  in  function  of  two  categorical  factors.  The  Graph  A  depicts  overall  effect  sizes  regarding
patient’s clinical  stage.  Likewise,  overall  effect  sizes  in  function  of  whether  the  psychological  intervention  is  applied  for  reducing
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vhe effects  of  ongoing  medical  oncologic  treatments  (adjuvant  
verall effect  sizes  for  all  categories  with  conﬁdence  interval  (
ategorical  model  ﬁtting
ategorical  models  were  tested  separately  to  analyze  the
nﬂuence  of  each  moderating  factor  on  the  effect  of  psy-
hological  treatments.  As  a  result,  two  signiﬁcant  models
howed  differences  between  categories.  The  ﬁrst  model
as  related  to  patient’s  clinical  state,  with  Qb (2)  =  10.37;
 <  .01.  Although,  we  reconsidered  these  analyses  in  order
o  clarify  the  true  effect  of  this  moderator.  Thus,  we  dis-
arded  the  studies  with  mixed  samples  and  the  studies  with
erminal  patients  due  to  the  small  sample  of  studies.  Hence,
linical  state  model  was  recalculated  using  two  categories:
urvivors  (k  =  9),  and  cancer  patients  under  medical  treat-
ent  (k  =  58).  As  a  result,  signiﬁcant  differences  were  again
ound  between  categories,  Qb (1)  =  3.89;  p  <  .05.  Figure  2
hows  the  overall  effect  sizes  of  these  categories.  Thus,  a
mall-to-medium  overall  effect  size  was  observed  in  stud-
es  which  analyzed  the  effects  of  psychological  treatments
n  survivors.  Studies  with  people  under  medical  treatment
howed  a  lower  effect  size.
Furthermore,  signiﬁcant  differences  between  categories
ere  found  regarding  the  use  of  adjuvant  psychological
reatment  (see  Figure  2),  with  Qb (1)  =  10.78;  p  <  .01.  Thus,
hen  psychological  treatment  was  applied  while  a  medical
reatment  was  ongoing  (k  =  11),  in  order  to  ameliorate  the
ide  effects,  the  overall  size  effect  was  greater  than  when
reatment  was  not  applied  for  these  purposes  (k  =  67).
uantitative  model  ﬁtting
verall  effect  size  was  calculated  for  the  quantitative
oderating  factors,  observing  small  overall  effect  sizesor  fatigue  (g  =  .21,  CI95 =  [.07,  .34];  Zc =  2.99,  p  <  .01)  and
epression  (g  =  .38,  CI95 =  [.21,  .54];  Zc =  4.45,  p  <  .01);  and
 medium  overall  effect  size  for  anxiety  (g  =  .54,  CI95 =  [.33,
76];  Zc =  4.88,  p  <  .01).
i
t
a
mment)  or  not,  are  presented  in  the  Graph  B.
een  square  brackets)  are  included.  ES  =  Effect  size.
Afterwards,  the  meta-regressive  models  were  estimated
ndependently.  The  model  composed  of  sociodemographic
nd  medical  factors  was  tested  ﬁrst,  but  a  non-signiﬁcant
ffect  was  found  for  that  (p  >  .05).  The  model  based  on
motional  factors  was  then  tested.  Thus,  signiﬁcant  ﬁtting
as  observed  for  this  model,  with  QR (2)  =  15.10;  p  < .01.
his  model  was  calculated  from  a  sample  of  32  studies  and
 considerable  explained  variance  of  criterion  was  found,
2 = .30.  However,  factorial  loading  for  depression,  and  not
nxiety,  was  revealed  as  signiﬁcantly  different  from  zero;
ith  B  =  .73,  CI95 =  (.35,  1.11);  and  Zc =  3.78;  p  <  .01.
These  results  highlight  the  importance  of  depressive
ymptomatology  ameliorations  in  order  to  delimit  the
ielded  effect  of  psychological  treatments  on  QoL.
ublication  bias
 contour-enhanced  funnel  plot  was  conducted  and  explored
rst  (see  Figure  3).  As  a  result,  it  was  possible  to  visual-
ze  that  a publication  bias  may  affect  the  results  of  this
eta-analysis,  due  to  the  presence  of  some  asymmetry
ithin  the  graph.  Egger’s  regression  test  supported  this  ﬁnd-
ng,  with  Z  =  5.75,  p  <  .05.  This  result  means  that  signiﬁcant
symmetry  was  found,  and  the  results  derived  from  this
eta-analysis  should  be  considered  cautiously.
iscussion
uality  of  life  and  related  constructs  become  more  relevant
ver  time  (e.g.,  see  Miret  et  al.,  2015).  In  fact,  QoL  is  one
f  the  most  important  concerns  for  cancer  patients  and  sur-
ivors.  This  state  should  be  considered  as  multidimensional
n  order  to  promote  integrative  patient-centered  care.  It  is
herefore  recommended  that  multidisciplinary  approaches
re  taking  within  oncologic  contexts.  Psychological  treat-
ents  should  take  part  in  this  context.  These  enable  a  better
Psychological  treatments  to  improve  quality  of  life  in  cancer  con
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Figure  3  Contour-enhanced  funnel  plot  for  publication  bias
detection.
Note. Statistical  nonsigniﬁcance  for  asymmetry  is  displayed  at
99% (white  area),  95%  (grey  area)  and  90%  (dark  grey  area)
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immune-mediated  responses  against  cancer.  Additionally,
tumor  expansion  is  encouraged  by  HPA-mediated  responsesconﬁdence  interval.
therapeutic  management  of  emotional  symptomatology  and
the  promotion  of  more  adaptive  coping  skills  in  order  to  ﬁght
against  cancer.  Consequently,  psychological  treatments  lead
to  improving  the  global  adjustment  to  daily  environment  and
increasing  the  sense  of  well-being  (Andersen  et  al.,  2010;
Cordella  &  Poiani,  2014).
This  study  aimed  to  shed  light  on  the  true  effects  of  psy-
chological  treatments  in  cancer  contexts.  Concretely,  the
effect  of  these  treatments  on  the  QoL  of  people  who  suf-
fer  from  cancer  or  survivors.  Moreover,  we  studied  whether
different  moderators  might  inﬂuence  this  outcome.
According  to  our  results,  a  statistically  signiﬁcant  over-
all  effect  size  of  psychological  treatments  was  observed
regarding  the  integrated  sense  of  QoL  of  cancer  patients
and  survivors.  Concretely,  a  small-to-medium  overall  effect
size  was  highlighted.  This  result  enables  us  to  suggest  that
psychological  treatments  yield  signiﬁcant  beneﬁts  on  QoL  in
cancer  patients.  This  effect  size  is  smaller  than  the  results
found  by  Rehse  and  Pukrop  (2003);  although  it  tends  to  agree
more  with  the  ones  shown  in  the  recent  meta-analysis  by
Faller  et  al.  (2013).  These  authors  showed  an  even  smaller
overall  effect  size  than  the  current  study.  It  is  likely  that
divergences  between  the  results  derived  from  these  two
meta-analyses  and  the  current  one  could  be  related  to
protocol  keeping  between  the  studies.  Firstly,  it  is  impor-
tant  to  highlight  that  the  current  study  considers  QoL  from
a  multidimensional  perspective.  Moreover,  psychological
treatments  were  conceptualized  according  to  Hodges  et  al.
(2011),  and  coded  following  the  classiﬁcation  of  Cunningham
(1995).  This  classiﬁcation  is  focused  on  patients’  needs  and
levels  of  involvement  in  their  recovery  process  along  the
disease  trajectory  (Hopkins  &  Mumber,  2009).  Conversely,
Faller  et  al.  (2013)  assumed  sample  selection  criteria  based
only  partially  on  these  referenced  frameworks  (i.e.,  only
face-to-face  treatments  were  considered  within  the  study,
ruling  out  treatments  that  incorporated  other  forms  of
t
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elivery);  indeed,  they  followed  another  classiﬁcation  of
sychological  treatments.
On  the  other  hand,  the  current  study  and  the  reference
nes  agree  upon  the  fact  that  psychological  treatments
annot  show  a  uniﬁed  effect  size.  In  our  meta-analysis,
wo  of  the  studied  variables  were  revealed  as  signiﬁcant
oderating  factors  in  this  regard.  The  ﬁrst  one  was  the
atient’s  clinical  state.  Thus,  it  was  found  that  psycho-
ogical  treatments  promote  greater  QoL  for  survivors.  The
eneﬁts  of  psychological  treatments  seemed  to  fade  away
n  patients  under  active  treatment.  Medical  treatments
oward  the  healing  may  be  rather  more  crucial  through-
ut  cancer  healing  process.  Nevertheless,  psychological
reatments  become  more  effective  when  patients  had  to
ope  with  the  side  effects  of  ongoing  medical  treatments,
uch  as  surgery,  chemotherapy  or  radiotherapy  (Cheung,
olassiotis,  &  Chang,  2003;  Svensk  et  al.,  2009).  Hence,
he  effect  of  reducing  somatic  anxiety,  sleep  problems  or
ther  symptomatology  which  are  a  consequence  of  medi-
al  treatments  is  noteworthy.  Furthermore,  when  cancer  is
reated,  psychological  treatments  can  play  a  more  impor-
ant  role,  as  the  results  of  this  meta-analysis  highlight.  A
erson  who  recovers  from  a  cancer  has  to  adapt  to  daily
ife  in  different  conditions  than  before.  Thus,  survivors  tend
o  show  some  physical  and  psychological  sequelae,  situa-
ions  of  disability  and  handicap,  and  important  contextual
hanges  (job  loss,  new  familiar  roles,  etc.).  These  events
aken  together  impact  well-being  and  QoL  and  can  be  coped
ith  more  effectively  by  the  aid  of  psychological  treatments
Mann  et  al.,  2012;  Osborn  et  al.,  2006).
It  also  is  noteworthy  that  this  study  found  no  signiﬁcant
ffects  of  other  moderators.  Thus,  neither  other  medical
actors  nor  intervention-related  aspects  studied  showed  a
igniﬁcant  inﬂuence  on  the  psychological-treatment  effects
n  QoL.  This  fact  is  not  aligned  with  ﬁndings  from  the
forementioned  works  (Faller  et  al.,  2013;  Rehse  &  Pukrop,
003),  probably  due  to  different  conceptualizations  and
he  incorporation  of  more  recent  studies.  Regarding  other
odulating  factors,  the  role  of  depressive  symptomatology
meliorations  should  be  highlighted  to  address  the  bene-
ts  of  psychological  treatments  within  oncologic  contexts.
n  this  sense,  the  psychological  treatments  that  promoted
reater  reductions  in  depressive  symptomatology  yielded
reater  beneﬁts  on  QoL.  This  statement  was  endorsed  by
he  results  derived  from  the  meta-regressive  analyses.  No
ther  statistically  signiﬁcant  loadings  were  found  neither  for
ociodemographic  features  of  patients,  medical  factors  nor
nxiety  ameliorations.
These  results  highlight  that  psychological  treatments
hich  ameliorate  depressive  symptomatology  can  promote
reater  levels  of  QoL  in  oncologic  contexts.  Depression,  and
ts  related  symptomatology,  is  considered  a  risk  factor  of
ancer  incidence  and  progression  (Boyd  et  al.,  2012;  Currier
 Nemeroff,  2014).  Hypothalamus-pituitary-adrenal  (HPA)
ysregulation  and  immunological  alterations  are  implied  in
his  status  (Lutgendorf  &  Sood,  2011;  Sotelo,  Musselman,
 Nemeroff,  2014;  Thornton,  Andersen,  &  Blakely,  2010).
epressive  symptomatology  therefore  impacts  defensivehat  are  characteristic  of  depressive  symptomatology.  Con-
equently,  decrements  of  depressive  symptomatology  may
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ead  to  cancer-related  adverse  effects  being  buffered  and
oL  becoming  higher  (Barrera  &  Spiegel,  2014;  Howren,
hristensen,  Karnell,  &  Funk,  2010).
To  sum  up,  this  study  highlights  a  signiﬁcant  small-to-
edium  overall  effect  size  of  psychological  treatments  on
oL,  within  cancer  contexts.  This  effect  should  be  con-
idered  when  taking  into  account  medical  variables  (the
atient’s  clinical  state  and  the  application  of  psychologi-
al  treatments  to  palliate  side  effects  of  a  medical  one).
oreover,  it  recommends  that  components  for  reducing
epressive  symptomatology  are  incorporated  into  psycho-
ogical  treatment.
As  strengths,  this  meta-analysis  includes  a  wide  amount
f  studies,  encompassing  both  more  classical  and  more
ecent  ones,  keeping  well-validated  protocols  which  were
sed  in  the  reference  study.  Indeed,  robust  deﬁnitions  were
onsidered  and  a  multidimensional  perspective  to  view  QoL
as  followed.  These  strengths  enable  us  to  provide  some
vidence  in  order  to  complement  prior  prominent  ﬁndings
Faller  et  al.,  2013;  Rehse  &  Pukrop,  2003).  This  study  there-
ore  suggests  that  psychological  treatments  yield  signiﬁcant
mprovements  on  QoL,  provided  that  the  medical  state  of
atient  is  taken  into  account.
As  limitations,  this  meta-analysis  could  have  incorpo-
ated  other  types  of  studies  (i.e.,  pre-experimental  studies)
ven  though  these  studies  had  a  lower  methodological  qual-
ty.  However,  in  this  case,  variables  related  to  the  absence
f  experimental  controls  could  have  been  added  and  could
ave  stained  the  actual  results  of  this  meta-analysis.  On  the
ther  hand,  other  modulating  factors  could  have  been  con-
idered  (i.e.,  experience  of  implementers,  personality  traits
f  patients,  etc.).  Future  research  should  incorporate  these
n  order  to  clarify  the  true  effects  of  psychological  treat-
ents.  Finally,  the  presence  of  publication  bias  is  pointed
ut  in  this  study  as  well  as  in  other  related  meta-analyses
Faller  et  al.,  2013;  Osborn  et  al.,  2006);  this  involves  that
hese  results  should  be  considered  cautiously.
This  study  intends  to  contribute  toward  understanding
he  disease  burden  of  cancer  and  the  importance  of  psycho-
ogical  interventions,  as  well  as  suggesting  populations  most
ikely  to  help.  Psychological  treatments  play  a  signiﬁcant
ole  in  integrated  care  within  cancer  contexts.  These  treat-
ents  help  improve  mental  health  and  personal  well-being
hroughout  the  trajectory  of  the  potentially  life-threatening
ancer  experience.  Well-being  and  QoL  remain  as  crucial
actors  to  promote  successful  adjustment  to  daily  environ-
ents  after  overcoming  this  disease.
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